Investigation of serum afamin concentration in pregnant women diagnosed with late fetal growth restriction or small for gestational age fetus

References

• Nardozza LMM, Caetano ACR, Zamarian ACP, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017;295(5):1061–1077. doi:10.1007/s00404-017-4341-9.
   PubMed Web of Science ®Google Scholar
• Gordijn SJ, Beune IM, Thilaganathan B, et al. Consensus definition of fetal growth restriction: a Delphi procedure: consensus definition of FGR. Ultrasound Obstet Gynecol. 2016;48(3):333–339. doi:10.1002/uog.15884.
   PubMed Web of Science ®Google Scholar
• Audette MC, Kingdom JC. Screening for fetal growth restriction and placental insufficiency. Semin Fetal Neonatal Med. 2018;23(2):119–125. doi:10.1016/j.siny.2017.11.004.
   PubMed Web of Science ®Google Scholar
• Lees CC, Stampalija T, Baschat AA, et al. ISUOG practice guidelines: diagnosis and management of small‐for‐gestational‐age fetus and fetal growth restriction. Ultrasound Obstet Gynecol. 2020;56(2):298–312. doi:10.1002/uog.22134.
   PubMed Web of Science ®Google Scholar
• Unterscheider J, Daly S, Geary MP, et al. Optimizing the definition of intrauterine growth restriction: the multicenter prospective Porto study. Am J Obstet Gynecol. 2013;208(4):290.e1–290–e6. doi:10.1016/j.ajog.2013.02.007.
   Web of Science ®Google Scholar
• Lichenstein HS, Lyons DE, Wurfel MM, et al. Afamin is a new member of the albumin, alpha-fetoprotein, and vitamin D-binding protein gene family. J Biol Chem. 1994;269(27):18149–18154. doi:10.1016/S0021-9258(17)32429-8.
   PubMed Web of Science ®Google Scholar
• Voegele AF, Jerković L, Wellenzohn B, et al. Characterization of the vitamin E-binding properties of human plasma afamin. Biochemistry. 2002;41(49):14532–14538. doi:10.1021/bi026513v.
   PubMed Web of Science ®Google Scholar
• Dieplinger B, Egger M, Gabriel C, et al. Analytical characterization and clinical evaluation of an enzyme-linked immunosorbent assay for measurement of afamin in human plasma. Clin Chim Acta. 2013;425:236–241. doi:10.1016/j.cca.2013.08.016.
   PubMed Web of Science ®Google Scholar
• Dieplinger H, Dieplinger B. Afamin–a pleiotropic glycoprotein involved in various disease states. Clin Chim Acta. 2015;446:105–110. doi:10.1016/j.cca.2015.04.010.
   PubMed Web of Science ®Google Scholar
• Hubalek M, Buchner H, Mörtl MG, et al. The vitamin E-binding protein afamin increases in maternal serum during pregnancy. Clin Chim Acta. 2014;434(100):41–47. doi:10.1016/j.cca.2014.03.036.
   PubMed Web of Science ®Google Scholar
• Atakul N, Atamer Y, Selek Ş, et al. Novel metabolic marker afamin: a predictive factor for Large-for-Gestational-Age (LGA) fetus estimation in pregnancies with gestational diabetes mellitus? J Gynecol Obstet Hum Reprod. 2021;50(10):102201. doi:10.1016/j.jogoh.2021.102201.
   PubMed Web of Science ®Google Scholar
• Basaran A. Pregnancy-induced hyperlipoproteinemia: review of the literature. Reprod Sci. 2009;16(5):431–437. doi:10.1177/1933719108330569.
   PubMed Web of Science ®Google Scholar
• Kronenberg F, Kollerits B, Kiechl S, et al. Plasma concentrations of afamin are associated with the prevalence and development of metabolic syndrome. Circ Cardiovasc Genet. 2014;7(6):822–829. doi:10.1161/CIRCGENETICS.113.000654.
   PubMedGoogle Scholar
• Köninger A, Enekwe A, Mach P, et al. Afamin: an early predictor of preeclampsia. Arch Gynecol Obstet. 2018;298(5):1009–1016. doi:10.1007/s00404-018-4897-z.
   PubMed Web of Science ®Google Scholar
• Çalışkan CS, Celik S, Avcı B. Is afamin a potential early biomarker for subsequent development of preeclampsia? A nested case–control study. J Matern Fetal Neonatal Med. 2021;34(12):2006–2011. doi:10.1080/14767058.2020.1818201.
   PubMed Web of Science ®Google Scholar
• Tramontana A, Pablik E, Stangl G, et al. Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies. Placenta. 2018;62:9–15. doi:10.1016/j.placenta.2017.12.014.
   PubMed Web of Science ®Google Scholar
• Köninger A, Mathan A, Mach P, et al. Is afamin a novel biomarker for gestational diabetes mellitus? A pilot study. Reprod Biol Endocrinol. 2018;16(1):30. doi:10.1186/s12958-018-0338-x.
   PubMed Web of Science ®Google Scholar
• Eroğlu H, Örgül G, Tonyalı NV, et al. The role of afamin and other trace elements in the prediction of GDM: a tertiary center experience. Biol Trace Elem Res. 2021;199(12):4418–4422. doi:10.1007/s12011-020-02559-0.
   PubMed Web of Science ®Google Scholar
• Wang X, Zheng X, Yan J, et al. The clinical values of afamin, triglyceride and PLR in predicting risk of gestational diabetes during early pregnancy. Front Endocrinol (Lausanne). 2021;12:723650. doi:10.3389/fendo.2021.723650.
   PubMed Web of Science ®Google Scholar